GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinovac Biotech Ltd (FRA:SVQ) » Definitions » Shiller PE Ratio

Sinovac Biotech (FRA:SVQ) Shiller PE Ratio : 0.84 (As of May. 22, 2024)


View and export this data going back to . Start your Free Trial

What is Sinovac Biotech Shiller PE Ratio?

As of today (2024-05-22), Sinovac Biotech's current share price is €5.58. Sinovac Biotech's E10 for the fiscal year that ended in Dec23 was €6.68. Sinovac Biotech's Shiller PE Ratio for today is 0.84.

The historical rank and industry rank for Sinovac Biotech's Shiller PE Ratio or its related term are showing as below:

FRA:SVQ' s Shiller PE Ratio Range Over the Past 10 Years
Min: 0.82   Med: 82.5   Max: 634
Current: 0.83

During the past 13 years, Sinovac Biotech's highest Shiller PE Ratio was 634.00. The lowest was 0.82. And the median was 82.50.

FRA:SVQ's Shiller PE Ratio is not ranked
in the Biotechnology industry.
Industry Median: 34.77 vs FRA:SVQ: 0.83

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sinovac Biotech's adjusted earnings per share data of for the fiscal year that ended in Dec23 was €-0.972. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €6.68 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sinovac Biotech Shiller PE Ratio Historical Data

The historical data trend for Sinovac Biotech's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinovac Biotech Shiller PE Ratio Chart

Sinovac Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.40 33.22 0.85 0.82 0.83

Sinovac Biotech Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 - 0.82 - 0.83

Competitive Comparison of Sinovac Biotech's Shiller PE Ratio

For the Biotechnology subindustry, Sinovac Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinovac Biotech's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinovac Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sinovac Biotech's Shiller PE Ratio falls into.



Sinovac Biotech Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sinovac Biotech's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=5.58/6.68
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinovac Biotech's E10 for the fiscal year that ended in Dec23 is calculated as:

For example, Sinovac Biotech's adjusted earnings per share data for the fiscal year that ended in Dec23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec23 (Change)*Current CPI (Dec23)
=-0.972/114.7809*114.7809
=-0.972

Current CPI (Dec23) = 114.7809.

Sinovac Biotech Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 -0.024 99.000 -0.028
201512 -0.028 100.600 -0.032
201612 -0.009 102.600 -0.010
201712 0.380 104.500 0.417
201812 0.299 106.500 0.322
201912 0.369 111.200 0.381
202012 0.797 111.500 0.820
202112 65.729 113.108 66.701
202212 0.944 115.116 0.941
202312 -0.972 114.781 -0.972

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sinovac Biotech  (FRA:SVQ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Sinovac Biotech Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Sinovac Biotech's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinovac Biotech (FRA:SVQ) Business Description

Traded in Other Exchanges
N/A
Address
No.39, Shangdi Xi Road, Haidan District, Beijing, CHN, 100085
Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.

Sinovac Biotech (FRA:SVQ) Headlines

No Headlines